The Global Alliance for TB Drug Development (TB Alliance) was established in 2000 as a not-for-profit product development partnership to lead the search for new TB regimens and catalyze global efforts for new TB regimens that can bring hope, and health, to millions.

The TB Alliance is actively working to develop and deliver improved pediatric TB treatments. To learn more about their work, please click here.

We would like to thank Cherise Scott and Irina Usherenko for their support in developing the MAP-IT model.